Form 4 for OGN Organon & Co.
Accepted 2025-02-24 00:00:00 ET · period of report 2025-02-20 · accession 0001859803-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-24 | 2025-02-20 | OGN | Falcione Aaron | CHRO | A - Grant | $0.00 | +16.6K | 44.1K | +60% | $0 |
| M | 2025-02-24 | 2025-02-20 | OGN | Falcione Aaron | CHRO | F - Tax | $14.97 | -6,035 | 46.0K | -12% | -$90.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-20 | A | A | 14,037 | $0.00 | 46,696 | D | — | — | (F1) Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 09, 2022 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors. |
| 2 | Common | Common Stock | 2025-02-20 | F | D | 5,154 | $14.92 | 41,542 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-20 | A | A | 2,571 | $0.00 | 44,113 | D | — | — | (F2) Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above. |
| 4 | Common | Common Stock | 2025-02-20 | F | D | 881 | $15.29 | 45,980.66 | D | — | — | (F3) Includes the addition of 2,748.661 shares of Common Stock acquired from dividend reinvestments not previously reported. |